EPIDUO GEL 0.1%/2.5% [SIN13789P]

Product Info

EPIDUO GEL 0.1%/2.5%

[SIN13789P]

4.1. Therapeutic indications
Cutaneous treatment of Acne vulgaris when comedones, papules and pustules are present (See section 5.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

4.2. Posology and method of administration
Epiduo should be applied to the entire acne affected areas once a day in the evening on a clean and dry skin. A thin film of gel should be applied, with the fingertips, avoiding the eyes and lips (see section 4.4 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
If irritation occurs, the patient should be directed to apply non-comedogenic moisturizers, to use the medication less frequently (e.g. every other day), to suspend use temporarily, or to discontinue use altogether.
The duration of treatment should be determined by the Doctor on the basis of the clinical condition. Early signs of clinical improvement usually appear after 1 to 4 weeks of treatment. The safety and effectiveness of Epiduo have not been studied in children below 9 years of age.

4.3. Contraindications
Pregnancy (see section 4.6 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
Women planning a pregnancy.
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.